{
  "id": 10471322,
  "title": "Up Over 550% in 2026, Is It Too Late to Buy Moderna Stock?",
  "url": "https://urgent.news/2026/09/28/up-over-550-in-2026-is-it-too-late-to-buy-moderna-stock-10471322",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-28T14:48:10.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/over-550-2026-it-too-late-buy-moderna-stock"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsIn mid-August, Moderna announced extremely encouraging results for intismeran, which sent its stock soaring.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "Up Over 550% in 2026, Is It Too Late to Buy Moderna Stock?",
        "url": "https://urgent.news/2026/09/28/up-over-550-in-2026-is-it-too-late-to-buy-moderna-stock",
        "published": "2026-09-28T14:28:10.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}